NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randall MoreadithChief Scientific Officer2025-06-306,500$5.78
$37.57kSell
Randall MoreadithChief Scientific Officer2025-06-306,500$0.06
$390.00Buy
Juvenescence Ltd10% Owner2025-01-31500,000$10.00
$5.00MBuy
Gregory BaileyDirector2024-12-173,866$4.59
$17.74kBuy
Juvenescence Ltd10% Owner2024-11-27500,000$10.00
$5.00MBuy
Gregory BaileyDirector2024-09-201,137$6.03
$6.85kBuy
Gregory BaileyDirector2024-09-1911,679$6.11
$71.38kBuy
Gregory BaileyDirector2024-09-182,709$6.23
$16.87kBuy
Steven MintzDirector2024-09-126,000$6.47
$38.81kBuy
Gregory BaileyDirector2024-08-201,776$8.25
$14.65kBuy

1 of 2

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd225.55%22,481,876$135.34MInsider
Juvenescence Us Corp165.01%16,447,500$99.01MInsider
Steven A. Ledger3.25%323,657$1.95MInsider
John F. Mauldin1.25%125,000$752.50kInsider
Broadwood Capital Inc0.85%85,219$513.02kInstitution
Waverly Advisors LLC0.68%67,492$406.30kInstitution
Gregory Bailey0.67%67,243$404.80kInsider
Vanguard Group Inc0.66%65,333$393.30kInstitution
Tacey Viegas0.59%58,610$352.83kInsider
Judith Segall0.53%52,624$316.80kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER0.84%99.16%Net BuyingNet Buying
RPTX55.91%44.09%Net Selling
BMEA55.29%44.71%Net Buying
MGX25.46%33.19%Net SellingNet Selling
ANRO75.60%24.40%Net Buying

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 3.37% institutional shareholders, 398.02% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 225.55% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $138.04M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.